Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eliquis for Treatment of Embolic Stroke of Undetermined Source (ATTICUS)
NCT02427126Phase 3Completed
- Sponsor
- University Hospital Tübingen
- Start
- Dec 2015
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in embolic stroke of undetermined source (ESUS), sponsored by University Hospital Tübingen. Started Dec 2015; status: completed.
02
Drugs
apixaban
03
Conditions
embolic stroke of undetermined source (ESUS)
Beyond the preview
Go deeper on NCT02427126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427126.